NeueHealth (NYSE:NEUE) Director Paul Edward Walker Sells 3,915 Shares

NeueHealth, Inc. (NYSE:NEUE) Director Paul Edward Walker sold 3,915 shares of the firm’s stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $6.75, for a total value of $26,426.25. Following the transaction, the director owned 488,702 shares in the company, valued at $3,298,738.50. This represents a 0.79% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

NeueHealth Stock Performance

Shares of NYSE NEUE opened at $6.75 on Tuesday. The stock has a market cap of $60.94 million, a P/E ratio of -0.42 and a beta of 0.59. NeueHealth, Inc. has a twelve month low of $3.79 and a twelve month high of $7.66. The stock has a 50 day moving average of $6.72 and a two-hundred day moving average of $6.73.

NeueHealth (NYSE:NEUE) last announced its earnings results on Thursday, August 7th. The company reported ($1.68) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($4.77) by $3.09. The business had revenue of $209.08 million for the quarter, compared to analysts’ expectations of $249.50 million. As a group, research analysts predict that NeueHealth, Inc. will post -9.13 earnings per share for the current year.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of NeueHealth in a research note on Saturday, September 27th. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Reduce” and a consensus target price of $7.00.

Institutional Investors Weigh In On NeueHealth

A hedge fund recently bought a new stake in NeueHealth stock. PenderFund Capital Management Ltd. acquired a new stake in NeueHealth, Inc. (NYSE:NEUE) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 29,115 shares of the company’s stock, valued at approximately $197,000. PenderFund Capital Management Ltd. owned 0.33% of NeueHealth as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 63.88% of the company’s stock.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.